Literature DB >> 17207416

Multiparticulate formulation approach to colon specific drug delivery: current perspectives.

Laila Fatima Ali Asghar1, Sajeev Chandran.   

Abstract

Colon specific drug delivery has gained increased importance not just for the delivery of drugs for the treatment of local diseases associated with the colon but also as potential site for the systemic delivery of therapeutic peptide and proteins. To achieve successful colon targeted drug delivery, a drug needs to be protected from degradation, release and/or absorption in the upper portion of the GI tract and then ensure abrupt or controlled release in the proximal colon. Drug modifications through covalent linkages with carrier or prodrug approach and formulation based approaches can be used for colonic delivery. Report suggests that drug carrier systems larger than 200 mm possess very low gastric transit time due to physiological condition of the bowel in colitis. And for this reason and considering the selective uptake of micron or sub-micron particles by cancerous and inflamed cells/ tissues a multiparticulate approach based on pellets, granules, microsphere or nanoparticle type formulation is expected to have better pharmacological effect in the colon. The review is aimed at understanding recent advancements made in multiparticulate formulation approach for colon specific delivery of medicaments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17207416

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  21 in total

1.  Eudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancer.

Authors:  Naveen K Thakral; Alok R Ray; Dipak K Majumdar
Journal:  J Mater Sci Mater Med       Date:  2010-06-10       Impact factor: 3.896

Review 2.  Biomagnetic methods: technologies applied to pharmaceutical research.

Authors:  Luciana A Corá; Madileine F Américo; Ricardo B Oliveira; Cristina H R Serra; Oswaldo Baffa; Raul C Evangelista; Giselle F Oliveira; José Ricardo Aruda Miranda
Journal:  Pharm Res       Date:  2010-10-15       Impact factor: 4.200

3.  Enhanced oral delivery of insulin via the colon-targeted nanocomposite system of organoclay/glycol chitosan/Eudragit®S100.

Authors:  Sang Hoon Lee; Seung-Yun Back; Jae Geun Song; Hyo-Kyung Han
Journal:  J Nanobiotechnology       Date:  2020-07-25       Impact factor: 10.435

4.  Pharmacokinetics of ketorolac tromethamine compression-coated tablets for colon delivery.

Authors:  Sateesh Kumar Vemula; Prabhakar Reddy Veerareddy; Venkat Ratnam Devadasu
Journal:  Drug Deliv Transl Res       Date:  2014-08       Impact factor: 4.617

5.  Acrylic acid-methyl methacrylate (2.5:7.5/2:8) enteric copolymer for colon targeted drug delivery.

Authors:  Saurabh Vijay; O P Sati; Dipak K Majumdar
Journal:  J Mater Sci Mater Med       Date:  2010-12-05       Impact factor: 3.896

6.  Development and Evaluation of pH-Dependent Micro Beads for Colon Targeting.

Authors:  M S Khan; B K Sridhar; A Srinatha
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

7.  Multiparticulate system for colon targeted delivery of ondansetron.

Authors:  S Jose; K Dhanya; T A Cinu; N A Aleykutty
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

8.  Pharmacokinetics of colon-specific pH and time-dependent flurbiprofen tablets.

Authors:  Sateesh Kumar Vemula; Prabhakar Reddy Veerareddy; Venkat Ratnam Devadasu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-06-11       Impact factor: 2.441

9.  Development of enteric submicron particle formulation of papain for oral delivery.

Authors:  Manu Sharma; Vinay Sharma; Amulya K Panda; Dipak K Majumdar
Journal:  Int J Nanomedicine       Date:  2011-09-23

10.  Factorial design-based development of measlamine microspheres for colonic delivery.

Authors:  Vikas Jain; Dayal Prasad; Deepika Jain; Santosh Kumar Mishra; Ranjit Singh
Journal:  Biomatter       Date:  2011 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.